chr3-52372379-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_015512.5(DNAH1):c.6819G>A(p.Leu2273Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00486 in 1,613,736 control chromosomes in the GnomAD database, including 607 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.0042   (  43   hom.,  cov: 33) 
 Exomes 𝑓:  0.0049   (  564   hom.  ) 
Consequence
 DNAH1
NM_015512.5 synonymous
NM_015512.5 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  4.13  
Publications
6 publications found 
Genes affected
 DNAH1  (HGNC:2940):  (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017] 
DNAH1 Gene-Disease associations (from GenCC):
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
 - ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
 - primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43). 
BP6
Variant 3-52372379-G-A is Benign according to our data. Variant chr3-52372379-G-A is described in ClinVar as Benign. ClinVar VariationId is 478482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.105  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DNAH1 | NM_015512.5  | c.6819G>A | p.Leu2273Leu | synonymous_variant | Exon 43 of 78 | ENST00000420323.7 | NP_056327.4 | |
| DNAH1 | XM_017006129.2  | c.6888G>A | p.Leu2296Leu | synonymous_variant | Exon 45 of 80 | XP_016861618.1 | ||
| DNAH1 | XM_017006130.2  | c.6819G>A | p.Leu2273Leu | synonymous_variant | Exon 44 of 79 | XP_016861619.1 | ||
| DNAH1 | XM_017006131.2  | c.6888G>A | p.Leu2296Leu | synonymous_variant | Exon 45 of 79 | XP_016861620.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00421  AC: 640AN: 152158Hom.:  43  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
640
AN: 
152158
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00919  AC: 2288AN: 248850 AF XY:  0.00892   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
2288
AN: 
248850
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00492  AC: 7195AN: 1461460Hom.:  564  Cov.: 32 AF XY:  0.00486  AC XY: 3536AN XY: 727022 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
7195
AN: 
1461460
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3536
AN XY: 
727022
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
33480
American (AMR) 
 AF: 
AC: 
10
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
6417
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
168
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
68
AN: 
53174
Middle Eastern (MID) 
 AF: 
AC: 
3
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
254
AN: 
1111856
Other (OTH) 
 AF: 
AC: 
274
AN: 
60372
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 349 
 699 
 1048 
 1398 
 1747 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 90 
 180 
 270 
 360 
 450 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00421  AC: 641AN: 152276Hom.:  43  Cov.: 33 AF XY:  0.00477  AC XY: 355AN XY: 74452 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
641
AN: 
152276
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
355
AN XY: 
74452
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
41550
American (AMR) 
 AF: 
AC: 
11
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
579
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
18
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
10
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
13
AN: 
68028
Other (OTH) 
 AF: 
AC: 
7
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 30 
 60 
 89 
 119 
 149 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
135
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
May 09, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37    Benign:1 
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.